Beyond Air (XAIR) Convertible Debt (2015 - 2016)
Beyond Air's (XAIR) quarterly Convertible Debt came in at $2.9 million in Q4 2016, up 86.53% year-over-year from $1.6 million in Q1 2016, and up 86.53% quarter-over-quarter from $1.6 million in Q4 2015.
Powered by 
Analysis
Beyond Air (XAIR) Convertible Debt (2015 - 2016) Analysis & Trends
Beyond Air has disclosed Convertible Debt across 2 years of filings, most recently posting $2.9 million for Q4 2016.
- In Q4 2016, Convertible Debt rose 86.53% year-over-year to $2.9 million; the TTM figure through Dec 2016 stood at $2.9 million (up 86.53% YoY), while the FY2016 annual figure was $2.9 million, up 86.53% from the prior year.
- Convertible Debt came in at $2.9 million for Q4 2016 at Beyond Air, up from $1.6 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $2.9 million in Q4 2016 to a low of $1.6 million in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.63 Bn | 175.03 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.57 Bn | 122.36 Bn | 1.96 Bn |
| 3 | Medtronic | 116.86 Bn | 108.04 Bn | 6.34 Bn |
| 4 | Stryker | 104.03 Bn | 100.55 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.67 Bn | 63.14 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.75 Bn | 45.50 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 20.70 Bn | 20.22 Bn | 684.20 Mn |
| 10 | Beyond Air | 2.24 Mn | -8.68 Mn | 225,000.00 |